Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Oral anticoagulation : Current overview and perioperative management in ophthalmic surgery].

Literature DB >> 29766263

[Oral anticoagulation : Current overview and perioperative management in ophthalmic surgery].

C Sucker¹, A Hager², J Koscielny³, N Feltgen⁴.

Abstract

Antithrombotic treatment with oral anticoagulants and antiplatelet agents can increase the risk for perioperative bleeding. In contrast to other surgical fields, the optimal perioperative management in ophthalmic surgery has not yet been exactly defined and, thus, is not standardized. In this contribution, we provide an overview of currently available oral anticoagulants and discuss potential strategies for the management of these agents in different ophthalmic surgical procedures.

Entities: Disease

Keywords: Management; Non-vitamin K antagonist oral anticoagulants; Ophthalmic surgery; Oral anticoagulants; Perioperative bleeding risk; Vitamin K antagonists

Mesh：

Substances：
Anticoagulants

Year: 2019 PMID： 29766263 DOI： 10.1007/s00347-018-0724-y

Source DB: PubMed Journal: Ophthalmologe ISSN： 0941-293X Impact factor: 1.059

Keyword Cloud
References

24 in total

1. Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients.

Authors: John O Mason; Paul A Frederick; Michael G Neimkin; Milton F White; Richard M Feist; Martin L Thomley; Michael A Albert
Journal: Retina Date: 2010-10 Impact factor: 4.256

10. The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications.

Authors: J D Benzimra; R L Johnston; P Jaycock; P H Galloway; G Lambert; A K K Chung; T Eke; J M Sparrow
Journal: Eye (Lond) Date: 2008-02-08 Impact factor: 3.775

[Oral anticoagulation : Current overview and perioperative management in ophthalmic surgery].

1. Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients.

2. Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients.

3. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.

4. [Perioperative conversion of oral anticoagulants to heparin (bridging) in ophthalmic medicine].

5. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery.

6. Safety of intravitreal injections in patients receiving warfarin anticoagulation.

7. Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery.

8. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery.

Review 9. Clinical use of new oral anticoagulant drugs: dabigatran and rivaroxaban.

10. The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications.